| Financial Year |
March 31 2023 |
| Monetary Funds |
4,292,213,117.68 |
| Held-for-trading Financial Assets |
2,018,994.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
85,483,658.91 |
| Advances to Suppliers |
47,718,664.87 |
| Other Receivables |
1,922,692,210.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
25,479,495,443.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,672,566,037.44 |
| Total Current Assets |
33,502,188,126.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,844,057,656.14 |
| Investment Properties |
305,333,109.67 |
| Fixed Assetes |
305,500,921.55 |
| Under-construction Projects |
434,253,600.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,126,243.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,987,171.08 |
| Deferred Income Tax Assets |
390,449,420.51 |
| Other Non-Current Assets |
1,317,447.07 |
| Sub-Total of Non-Current Assets |
4,457,278,959.62 |
| Total Assets |
37,959,467,086.53 |
| Short-Term Loans |
245,732,561.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,164,505,365.22 |
| Accounts Received In Advance |
7,262,529.07 |
| Employee Compensation Payable |
22,309,328.87 |
| Taxes Payable |
304,752,954.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,650,734,675.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,400,276,880.82 |
| Other Current Liabilities |
2,645,548,737.53 |
| Sub-Total of Current Liabilities |
30,490,669,176.96 |
| Long-term Loans |
2,377,733,624.54 |
| Bonds Payable |
92,390,488.47 |
| Long-Term Accounts Payable |
3,326,081.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,293,180,256.96 |
| Deferred Income Tax Liabilities |
20,863,880.12 |
| Other Non-Current Liabilities |
760,452,684.89 |
| Sub-Total of Non-Current Liabilities |
5,547,947,016.31 |
| Total Liabilities |
36,038,616,193.27 |
| Paid-In Capital(Or Share Stock) |
1,340,122,326.00 |
| Capital Surplus |
454,755,315.52 |
| Surplus Reserve |
334,906,312.95 |
| LESS:Treasury Stock |
297,482,763.31 |
| Undistributed Profits |
-1,120,710,508.80 |
| Minority Stockholder's Interest |
1,208,360,650.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
712,490,242.62 |
| Owner's Equity（Stockholder's Equity） |
1,920,850,893.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,959,467,086.53 |
